Table 10 Agreement between PET/CT and BMB in nodular sclerosis cases
From: PET/CT and bone marrow biopsy (BMB) in evaluating bone marrow in lymphoma
| Â | Â | BMB | Â | Total | |
|---|---|---|---|---|---|
Negative | Positive | Â | |||
PET/CT | Negative | Count | 38 | 1 | 39 |
% of total | 77.6% | 2.0% | 79.6% | ||
Positive | Count | 8 | 2 | 10 | |
% of total | 16.3% | 4.1% | 20.4% | ||
Total | Â | Count | 46 | 3 | 49 |
% of total | 93.9% | 6.1% | 100.0% | ||